|
End-of-day quote
Shanghai S.E.
24/09/2026
|
5-day change | 1st Jan Change | ||
| 9.880 CNY | -3.61% |
|
+6.81% | +1.86% |
| 08-27 | Sinotherapeutics Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-29 | Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 4.44B 661M 580M 548M 499M 934M 63.34B 941M 6.55B 2.54B 32.36B 2.48B 2.43B 104B | P/E 2024 |
35.9x | P/E 2025 | 88.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.69B 550M 482M 456M 415M 777M 52.68B 783M 5.45B 2.11B 26.91B 2.06B 2.02B 86.5B | EV / Sales 2024 |
7.4x | EV / Sales 2025 | 8.08x |
| Free-Float |
24.34% | Yield 2024 |
0.62% | Yield 2025 | 0.36% |
| 1 day | -3.61% | ||
| 1 week | +6.81% | ||
| Current month | +7.74% | ||
| 1 month | -0.40% | ||
| 3 months | +31.03% | ||
| 6 months | +6.70% | ||
| Current year | +1.86% |
| 1 week | 9.26 |  | 10.49 |
| 1 month | 8.43 | | 10.49 |
| Current year | 7.02 | | 11.33 |
| 1 year | 7.02 | | 11.46 |
| 3 years | 6.3 | | 14 |
| 5 years | 6.3 | | 28 |
| 10 years | 6.3 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Jie Guo
CEO | Chief Executive Officer | 53 | 05/04/2023 |
Yi Ming Wu
DFI | Director of Finance/CFO | 57 | 29/04/2025 |
Hui Zhang
IRC | Investor Relations Contact | 44 | 30/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Ye
CHM | Chairman | 53 | 17/08/2020 |
Xiao Ming Ying
BRD | Director/Board Member | 58 | 31/07/2012 |
Si Yu Shen
BRD | Director/Board Member | 44 | 31/08/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.61% | +6.81% | -8.09% | -13.10% | 661M | |
| +0.12% | +0.81% | +13.81% | +64.78% | 46.37B | |
| +1.09% | +0.36% | +39.50% | +107.67% | 37.26B | |
| +2.00% | +3.78% | +18.12% | +99.54% | 12.53B | |
| +0.05% | +0.37% | -7.29% | +18.68% | 11.8B | |
| 0.00% | 0.00% | +18.72% | +139.63% | 8.97B | |
| -1.34% | -2.73% | +27.67% | +37.52% | 7.09B | |
| -2.07% | -2.75% | +17.20% | +202.97% | 7.01B | |
| +1.43% | +2.22% | +43.10% | -14.21% | 7.29B | |
| -2.45% | -0.59% | -51.49% | +4.53% | 4.99B | |
| Average | -0.48% | +0.83% | +11.13% | +64.80% | 14.4B | |
| Weighted average by Cap. | +0.30% | +0.57% | +19.38% | +78.73% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 512M 76.22M 66.88M 63.16M 57.56M 108M 7.3B 109M 756M 293M 3.73B 286M 280M 11.99B | 447M 66.52M 58.38M 55.13M 50.24M 94.05M 6.38B 94.72M 660M 256M 3.26B 250M 244M 10.47B |
| Net income | 128M 19.02M 16.69M 15.77M 14.37M 26.9M 1.82B 27.09M 189M 73.07M 931M 71.43M 69.88M 2.99B | 47.48M 7.07M 6.21M 5.86M 5.34M 10M 678M 10.07M 70.15M 27.17M 346M 26.56M 25.98M 1.11B |
| Net Debt | -734M -109M -95.89M -90.56M -82.53M -154M -10.47B -156M -1.08B -420M -5.35B -410M -401M -17.2B | -746M -111M -97.57M -92.15M -83.98M -157M -10.66B -158M -1.1B -427M -5.44B -417M -408M -17.5B |
Employees
319
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/09/26 | CN¥9.880 | -3.61% | 9,297,134 |
| 23/09/26 | CN¥10.25 | +2.40% | 8,915,571 |
| 22/09/26 | CN¥10.01 | +0.50% | 8,870,059 |
| 21/09/26 | CN¥9.960 | +7.68% | 10,369,551 |
| 18/09/26 | CN¥9.250 | +0.76% | 7,037,465 |
- Stock Market
- Stocks
- 688247 Stock
Select your edition
All financial news and data tailored to specific country editions
